Validation of Low Dose CT for Diagnosis of Lung Nodules
The investigators have developed an extremely low dose computed tomography (CT) protocol that on preliminary testing has an effective dose in the range of two chest radiographs. The investigators plan to test this exam in patients with known or suspected cancer undergoing clinically indicated chest CT.
Checked against the public recordLast updated Aug 15, 2022 · Source: ClinicalTrials.gov
What this study is about
- Purpose
- Diagnostic
- Study type
- Interventional
- Phase
- Not applicable
- Sponsor
- Children's Hospital Medical Center, Cincinnati
- Interventions being studied
- Diagnostic Test: Extremely Low Dose CT
How this study is categorized
These labels come from structured fields and exact terms in the public record.
Who may be able to participate
Inclusion Criteria: * Pediatric and young adult patients (ages 4 to \<21 years) * Known or suspected malignancy other than lymphoma * Undergoing clinically indicated CT of the chest Exclusion Criteria: * Pregnancy identified by routine Department of Radiology verbal screening * Prior enrollment in the same study (no patient will be enrolled more than once) * Inability to provide consent and/or assent * Lymphoma
Important: This is the sponsor’s public criteria, not a determination of eligibility. The study team must review your individual situation.
U.S. locations
- Cincinnati Children's Hospital Medical Center Burnet CampusCincinnati, Ohio
Source and freshness
Processed from ClinicalTrials.gov. Last public update: Aug 15, 2022. Always confirm current availability with the study team.